Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
复制标题
DOI:
10.1001/jamaoncol.2017.0424
复制
发表时间:
2017-09-01
期刊:
影响因子:
28.4
通讯作者:
Dolinsky JS
中科院分区:
文献类型:
--
作者:
Couch FJ;Shimelis H;Hu C;Hart SN;Polley EC;Na J;Hallberg E;Moore R;Thomas A;Lilyquist J;Feng B;McFarland R;Pesaran T;Huether R;LaDuca H;Chao EC;Goldgar DE;Dolinsky JS
Germline pathogenic variants in BRCA1 and BRCA2 predispose to an increased lifetime risk of breast cancer. However, the relevance of germline variants in other genes from multigene hereditary cancer testing panels is not well defined. To determine the risks of breast cancer associated with germline variants in cancer predisposition genes. A study population of 65 057 patients with breast cancer receiving germline genetic testing of cancer predisposition genes with hereditary cancer multigene panels. Associations between pathogenic variants in non-BRCA1 and non-BRCA2 predisposition genes and breast cancer risk were estimated in a case-control analysis of patients with breast cancer and Exome Aggregation Consortium reference controls. The women underwent testing between March 15, 2012, and June 30, 2016. Breast cancer risk conferred by pathogenic variants in non-BRCA1 and non-BRCA2 predisposition genes. The mean (SD) age at diagnosis for the 65 057 women included in the analysis was 48.5 (11.1) years. The frequency of pathogenic variants in 21 panel genes identified in 41 611 consecutively tested white women with breast cancer was estimated at 10.2%. After exclusion of BRCA1, BRCA2, and syndromic breast cancer genes (CDH1, PTEN, and TP53), observed pathogenic variants in 5 of 16 genes were associated with high or moderately increased risks ofbreast cancer: ATM (OR, 2.78; 95% CI, 2.22-3.62), BARD1 (OR, 2.16; 95% CI, 1.31-3.63), CHEK2 (OR, 1.48; 95% CI, 1.31-1.67), PALB2 (OR, 7.46; 95% CI, 5.12-11.19), and RAD51D (OR, 3.07; 95% CI, 1.21-7.88). Conversely, variants in the BRIP1 and RAD51C ovarian cancer risk genes; the MREHA, RAD50, and NBN MRN complex genes; the MLH1 and PMS2 mismatch repair genes; and NF1 were not associated with increased risks of breast cancer. This study establishes several panel genes as high- and moderate-risk breast cancer genes and provides estimates of breast cancer risk associated with pathogenic variants in these genes among individuals qualifying for clinical genetic testing.
登录
查看更多内容
影响因子:
28.4
作者:
Norquist BM;Harrell MI;Brady MF;Walsh T;Lee MK;Gulsuner S;Bernards SS;Casadei S;Yi Q;Burger RA;Chan JK;Davidson SA;Mannel RS;DiSilvestro PA;Lankes HA;Ramirez NC;King MC;Swisher EM;Birrer MJ
通讯作者:
Birrer MJ
DOI:
10.1186/bcr2919
发表时间:
2011-07-25
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Goldgar DE;Healey S;Dowty JG;Da Silva L;Chen X;Spurdle AB;Terry MB;Daly MJ;Buys SM;Southey MC;Andrulis I;John EM;BCFR;kConFab;Khanna KK;Hopper JL;Oefner PJ;Lakhani S;Chenevix-Trench G
通讯作者:
Chenevix-Trench G
DOI:
10.1038/gim.2014.40
发表时间:
2014-11
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1186/bcr3405
发表时间:
2013-03-19
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Win AK;Lindor NM;Jenkins MA
通讯作者:
Jenkins MA
DOI:
10.1073/pnas.1007983107
发表时间:
2010-07-13
影响因子:
11.1
作者:
Walsh, Tom;Lee, Ming K.;King, Mary-Claire
通讯作者:
King, Mary-Claire